Buspirone in detoxification.
Travers
R
R
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D001569:Benzodiazepines; D015982:Bias; D002065:Buspirone / Q000627:therapeutic use*; D006801:Humans; D010352:Patient Dropouts / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000534:rehabilitation*; D019966:Substance-Related Disorders / Q000534:rehabilitation*
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D002065:Buspirone